House Bill No. 1797 introduces new regulations regarding drug testing and prescription drug policies for employees and independent contractors of state agencies and political subdivisions in Texas, specifically concerning the medical use of low-THC cannabis and hemp. The bill establishes Chapter 621 in the Government Code, which includes definitions for terms such as "drug test," "hemp," and "low-THC cannabis." It outlines exceptions to the chapter, indicating that it does not apply to peace officers or employees subject to federal drug testing regulations.

The bill prohibits state agencies and political subdivisions from implementing drug testing policies that require employees or contractors to submit to tests for cannabinoids, establish negative test results as a condition of employment, or restrict the use of low-THC cannabis and hemp products. Additionally, it ensures medical privacy by preventing agencies from inquiring about an employee's use of these substances and mandates compliance with relevant privacy laws. The bill also provides for legal recourse, allowing individuals to seek damages or relief for violations of these provisions, and waives sovereign immunity for claims related to these sections. The act is set to take effect on September 1, 2025.

Statutes affected:
Introduced: ()